David W. Boyer Neurocrine Biosciences Inc (NBIX) insider trading activity

David W. Boyer is Chief Corp. Affairs Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 3,565 shares of NBIX, which is worth approximately $423,236. The most recent transaction as insider was on Feb 13, 2025, when has been sold 1,785 shares (Common Stock) at a price of $116.74 per share, resulting in proceeds of $208,380. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.57K

845.62% 3M change

27.17% 12M change

Total Value Held $423,236

David W. Boyer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2025	SELL Open market or private sale	$208,380 $116.74 p/Share	1,785 Reduced 33.36%	3,565 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	3,352 Added 43.27%	4,395 Common Stock
Feb 10 2025	SELL Open market or private sale	$82,817 $118.31 p/Share	700 Reduced 25.95%	1,998 Common Stock
Feb 08 2025	BUY Exercise of conversion of derivative security	-	1,329 Added 33.0%	2,698 Common Stock
Jan 31 2025	SELL Open market or private sale	$168,845 $152.94 p/Share	1,104 Reduced 44.64%	1,369 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	-	2,096 Added 45.87%	2,473 Common Stock
Oct 03 2024	SELL Open market or private sale	$147,189 $113.66 p/Share	1,295 Reduced 77.45%	377 Common Stock
Sep 13 2024	SELL Open market or private sale	$421,826 $121.88 p/Share	3,461 Reduced 67.43%	1,672 Common Stock
Feb 13 2024	SELL Open market or private sale	$241,007 $133.08 p/Share	1,811 Reduced 27.01%	4,895 Common Stock
Feb 08 2024	SELL Open market or private sale	$179,930 $135.49 p/Share	1,328 Reduced 21.34%	4,895 Common Stock
Feb 06 2024	SELL Open market or private sale	$64,733 $141.96 p/Share	456 Reduced 8.52%	4,894 Common Stock
Jan 31 2024	SELL Open market or private sale	$295,095 $140.79 p/Share	2,096 Reduced 29.99%	4,894 Common Stock
Oct 02 2023	SELL Open market or private sale	$161,921 $112.68 p/Share	1,437 Reduced 22.7%	4,894 Common Stock
Aug 30 2023	SELL Open market or private sale	$293,961 $107.56 p/Share	2,733 Reduced 44.13%	3,460 Common Stock
Aug 21 2023	SELL Open market or private sale	$171,856 $107.41 p/Share	1,600 Reduced 20.53%	6,193 Common Stock
Feb 08 2023	SELL Open market or private sale	$72,877 $104.11 p/Share	700 Reduced 12.83%	4,755 Common Stock
Feb 07 2023	SELL Open market or private sale	$2,488,601 $102.42 p/Share	24,298 Reduced 85.48%	4,127 Common Stock
Feb 06 2023	SELL Open market or private sale	$25,346 $105.61 p/Share	240 Reduced 5.5%	4,127 Common Stock
Jan 31 2023	SELL Open market or private sale	$121,351 $109.92 p/Share	1,104 Reduced 22.01%	3,911 Common Stock
Oct 31 2022	SELL Open market or private sale	$147,785 $114.12 p/Share	1,295 Reduced 30.73%	2,919 Common Stock
Oct 03 2022	SELL Open market or private sale	$153,170 $106.59 p/Share	1,437 Reduced 25.43%	4,214 Common Stock
Feb 08 2022	SELL Open market or private sale	$55,734 $79.62 p/Share	700 Reduced 19.34%	2,919 Common Stock
Feb 07 2022	SELL Open market or private sale	$19,457 $81.07 p/Share	240 Reduced 9.48%	2,291 Common Stock

DWB

David W. Boyer

Chief Corp. Affairs Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account